We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacological inhibition of AKT sensitizes MCF-7 human breast cancer-initiating cells to radiation.
- Authors
Zhan, Jun-Fang; Wu, Liang-Ping; Chen, Long-Hua; Yuan, Ya-Wei; Xie, Guo-Zhu; Sun, Ai-Min; Liu, Ying; Chen, Zhi-Xian
- Abstract
Background: Caner-initiating cells (CICs or cancer stem cells) have been shown both experimentally and clinically to be resistant to radiation. The mechanism underlying radioresistance remains unclear. Methods: In the present study, we screened 51 genes which are potentially important in mediating radioresistance of breast CICs. Results: The expression of AKT1 and AKT2 at protein and mRNA levels was dramatically increased among the screened genes by 8 Gy radiation treatment in MCF-7 mammosphere cells (predominantly CD24/CD44 CICs), but not in the bulk population of MCF-7 cells (predominantly CD24/CD44). Using apoptosis and clonogenic survival assays, we found pharmacological inhibition of AKT with selective inhibitors of AKT sensitized MCF-7 mammosphere cells, but not MCF-7 monolayer cells to radiation. Conclusion: The present findings suggest that treatment with AKT inhibitors prior to ionizing radiation treatment may be a potential benefit to patients with breast cancer, in particular to eradiate breast CICs.
- Subjects
BREAST cancer; STEM cells; CANCER cells; CANCER radiotherapy; CANCER treatment; APOPTOSIS
- Publication
Cellular Oncology (2211-3428), 2011, Vol 34, Issue 5, p451
- ISSN
2211-3428
- Publication type
Article
- DOI
10.1007/s13402-011-0020-1